← Back to Search

Behavioural Intervention

Walking Program for High Blood Pressure

N/A

Waitlist Available

Led By Duck-chul Lee, PhD

Research Sponsored by Iowa State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Men and women aged 65 years and above

Respiratory impairment as assessed by abnormal spirometry (a lung function test). Abnormal spirometric phenotypes include obstructive pattern, restrictive pattern, mixed obstructive/restrictive, and preserved ratio impaired spirometry (PRISm)

Must not have

Significant mobility limitation (e.g., severe arthritis) that would hinder the ability to increase daily steps

Admission to hospital for a respiratory-related illness (e.g., COPD exacerbation, pneumonia, lung injury, etc.) within the last 3 months

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 8-weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial will assess if an 8-week walking program can lower blood pressure in older adults with respiratory impairment, reducing their risk of CVD.

Who is the study for?

This trial is for inactive adults aged 65+ with respiratory issues and high blood pressure (systolic 120-159 mmHg), who are non-smokers, have a BMI <42kg/m2, and take fewer than 7,000 steps daily. They must be willing to increase their walking but can't join if they've had recent serious health events like stroke or heart attack, use oxygen supplements, or have mobility-limiting conditions.

What is being tested?

The study tests whether an 8-week program of increased lifestyle walking lowers blood pressure in older adults with breathing problems. Participants will either follow the walking program or receive only health education about managing their condition.

What are the potential side effects?

While there may not be direct side effects from increased walking or health education, participants should watch for any discomfort due to physical activity such as joint pain, fatigue, or shortness of breath.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 65 years old or older.

Select...

My lung function test shows I have breathing problems.

Select...

My blood pressure is between 120 and 159 mmHg, or I am on medication for high blood pressure.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have a condition like severe arthritis that makes it hard for me to walk more each day.

Select...

I was hospitalized for a lung-related illness in the last 3 months.

Select...

I have a neurological condition like Alzheimer's or Parkinson's.

Select...

I use supplemental oxygen.

Select...

I use a cane or walker for mobility.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 8-weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~8-weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 8-weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in systolic blood pressure

Secondary study objectives

Feasibility of conducting the study

Other study objectives

Change in SPPB performance

Change in arterial stiffness

Change in cognitive performance

+8 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Increased lifestyle walking (intervention)Experimental Treatment1 Intervention

Intentional increase in daily steps: 3,000 extra steps/day, 5-days a week, 8-weeks total.

Group II: Health education only (control)Experimental Treatment1 Intervention

Health education and no intentional increase in baseline daily steps (but with the option to receive the intervention upon conclusion of the initial 8-weeks).

0 / 8Eligibility criteria met